Get started
Apyx Medical CorporationApyx Medical CorporationApyx Medical Corporation

Apyx Medical Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

APYX chart


Full chart

APYX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪36.21 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.6648 USD
Net income (FY)
‪−23.46 M‬ USD
Revenue (FY)
‪48.10 M‬ USD
Shares float
‪32.17 M‬
Beta (1Y)
2.38

Employees


Employees (FY)
220
Change (1Y)
−32 −12.70%
Revenue / Employee (1Y)
‪218.65 K‬ USD
Net income / Employee (1Y)
‪−106.65 K‬ USD

About Apyx Medical Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Charles D. Goodwin
Website
apyxmedical.com
Headquarters
Clearwater
Founded
1978
FIGI
BBG000F4B671
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacturer (OEM). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

APYX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as APYX.

Frequently Asked Questions


The current price of APYX is 1.0700 USD — it has increased by 3.34% in the past 24 hours. Watch Apyx Medical Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Apyx Medical Corporation stocks are traded under the ticker APYX.
APYX stock hasn't changed in a week, the month change is a −2.94% fall, over the last year Apyx Medical Corporation has showed a −30.52% decrease.
We've gathered analysts' opinions on Apyx Medical Corporation future price: according to them, APYX price has a max estimate of 4.00 USD and a min estimate of 4.00 USD. Watch APYX chart and read a more detailed Apyx Medical Corporation stock forecast: see what analysts think of Apyx Medical Corporation and suggest that you do with its stocks.
APYX reached its all-time high on Nov 22, 2021 with the price of 17.5000 USD, and its all-time low was 0.5500 USD and was reached on Nov 29, 2002. View more price dynamics on APYX chart.
See other stocks reaching their highest and lowest prices.
APYX stock is 17.54% volatile and has beta coefficient of 2.38. Track Apyx Medical Corporation stock price on the chart and check out the list of the most volatile stocks — is Apyx Medical Corporation there?
Today Apyx Medical Corporation has the market capitalization of ‪40.44 M‬, it has decreased by −20.00% over the last week.
Yes, you can track Apyx Medical Corporation financials in yearly and quarterly reports right on TradingView.
Apyx Medical Corporation is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
APYX earnings for the last quarter are −0.12 USD per share, whereas the estimation was −0.16 USD resulting in a 24.81% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about Apyx Medical Corporation earnings.
Apyx Medical Corporation revenue for the last quarter amounts to ‪14.22 M‬ USD, despite the estimated figure of ‪13.39 M‬ USD. In the next quarter, revenue is expected to reach ‪9.39 M‬ USD.
APYX net income for the last quarter is ‪−4.63 M‬ USD, while the quarter before that showed ‪−4.70 M‬ USD of net income which accounts for 1.59% change. Track more Apyx Medical Corporation financial stats to get the full picture.
No, APYX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 220 employees. See our rating of the largest employees — is Apyx Medical Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Apyx Medical Corporation EBITDA is ‪−18.25 M‬ USD, and current EBITDA margin is −37.93%. See more stats in Apyx Medical Corporation financial statements.
Like other stocks, APYX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Apyx Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Apyx Medical Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Apyx Medical Corporation stock shows the sell signal. See more of Apyx Medical Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.